creative insight studios portfolio
Content Writing and Design Examples
featured project
Cyber Security
Greg Bednarski, Chief of Cyber Policy and Strategy at the National Security Agency’s Cybersecurity Directorate, Emphasizes NSA’s Expanded Cyber Outreach
Speaking at the January 2022 NSF-ISR Information Security Symposium, he talked about his agency’s increased efforts to engage private sector partners in efforts to protect against increasing cyber-attacks.
MARCH 2022 – 2 minute read
Cisco’s Barry Yuan Believes That Companies and Organizations Need To Adopt a ‘Zero Trust’ Approach To Defend Against the Rise In Ransomware Attacks
He recommends building a culture of cybersecurity compliance within operations combined with a ‘Zero Trust’ approach as an effective response to ransomware threats.
FEBRUARY 2022 – 2 minute read
John Strand of Black Hills Information Security Has a Two-Word Message for His Information Security Colleagues: ‘Creativity and Collaboration’
Creative approaches can sometimes create tension with clients, but when combined with collaboration can result in effective data security solutions.
FEBRUARY 2022 – 2 minute read
Pioneer Telephone Leverages Rapid7’s Insight Platform to Increase Visibility, Manage Vulnerability and Reduce Attack Risk Across Its Telecom Networks
Pioneer uses InsightIDR, InsightVM, InsightConnect and Nexpose to protect vital telecom networks that serve more than 150,000 customers, 1,700 users and 600 staff spread across 27 locations.
MARCH 2022 – 2 minute read
The US Signal Approach to Network Security: The Right People Working with the Right Tools to Manage Potential Vulnerabilities
That’s how the security team at US Signal protects the company’s sprawling network and cloud platforms for their Midwest customers.
FEBRUARY 2022 – 2 minute read

WHAT WE DO
Corporate Films for Innovative Companies and Organizations
FEATURED PROJECT
The film story of the Tucson Museum of Art’s brand new $3M Kasser Family Wing of LatinAmerica Art.
FEATURED PROJECT
The film story of Regulonix, a biomedical company on a quest to develop a non-opioid drug for severe, chronic pain.
